Company Search:
Advanced Search
Sponsored Links
Cytotools Ag Company Snapshot
Cytotools Ag operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cytotools Ag with three other pharmaceutical manufacturers in Europe: Bionor Pharma ASA of Norway (2014 sales of 1.77 million Norwegian Kroner [US$216,599.90 ] of which 93% was Soy-Based Products), Vicore Pharma Holding AB of Sweden (851,000.00 Swedish Kronor [US$96,409.79 ] ), and Immupharma PLC which is based in the United Kingdom (£184,815.00 [US$227,324.30 ] of which 100% was Pharmaceutical Research & Development).

Sales Analysis. Sales increased substantially in 2014: During the year ended December of 2014, sales at Cytotools Ag were 300,494.24 Euro (US$329.85 thousand). This is an increase of 501.0% versus 2013, when the company's sales were 50,000.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cytotools Ag
  Stock Performance Chart for Cytotools Ag
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 8.80
(Figures in Euro)
1 Week -10.3%   13 Weeks -12.8%  
4 Weeks -18.7%   52 Weeks -81.2%  
Cytotools Ag Key Data:
  Ticker: T5O Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2014 Sales 300,494
(Year Ending Jan 2015).
Employees: 1
  Currency: Euro Market Cap: 17,476,800
  Fiscal Yr Ends: December Shares Outstanding: 1,986,000
  Share Type: Inhaberstammaktien Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.